086849345	086849345	CD	B-NP	O
|	|	NNP	I-NP	O
ITGH	ITGH	NNP	I-NP	O
|	|	VBD	B-VP	O
45107454	45107454	CD	B-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
0322711	0322711	CD	B-NP	O
|	|	CC	I-NP	O
3/20/2003	3/20/2003	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
bronchitis	bronchitis	NN	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
3/15/2003	3/15/2003	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
3/7/2003	3/7/2003	CD	B-NP	O
******	******	SYM	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	O	O
DANSBY	DANSBY	NNP	B-NP	O
,	,	,	O	O
ABEL	ABEL	NNP	B-NP	O
546-35-72-6	546-35-72-6	CD	I-NP	O
OH	OH	NNP	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
MED	MED	NNP	B-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
PATIENT	PATIENT	NNP	I-NP	O
ON	ON	NNP	I-NP	O
:	:	:	O	O
8/20/03	8/20/03	CD	B-NP	O
AT	AT	NN	I-NP	O
03	03	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
PM	PM	NN	I-NP	O
CONTINGENT	CONTINGENT	NN	I-NP	O
UPON	UPON	NN	I-NP	O
HO	HO	NN	I-NP	O
evaluation	evaluation	NN	I-NP	O
WILL	WILL	MD	B-VP	O
D/C	D/C	NNP	B-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
BONIELLO	BONIELLO	NNP	B-NP	O
,	,	,	O	O
DOUGLASS	DOUGLASS	NNP	B-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
CODE	CODE	NNP	I-NP	O
STATUS	STATUS	NNP	I-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Home	Home	NN	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
services	service	NNS	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
ECASA	ECASA	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ASPIRIN	ASPIRIN	NNP	I-NP	O
ENTERIC	ENTERIC	NNP	I-NP	O
COATED	COATED	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
325	325	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
5/5/03	5/5/03	CD	B-NP	O
by	by	IN	B-PP	O
KRULISH	KRULISH	NN	B-NP	O
,	,	,	O	O
DARIUS	DARIUS	NNP	B-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
DEFINITE	DEFINITE	NNP	I-NP	O
ALLERGY	ALLERGY	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
OR	OR	NNP	I-NP	O
SENSITIVITY	SENSITIVITY	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
to	to	TO	B-PP	O
G6PD	G6PD	NN	B-NP	O
DEFICIENCY	DEFICIENCY	NN	I-NP	O
DEFINITE	DEFINITE	NN	I-NP	O
ALLERGY	ALLERGY	NN	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
OR	OR	NNP	I-NP	O
SENSITIVITY	SENSITIVITY	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
to	to	TO	B-PP	O
G6PD	G6PD	NN	B-NP	O
DEFICIENCY	DEFICIENCY	NN	I-NP	O
DEFINITE	DEFINITE	NN	I-NP	O
ALLERGY	ALLERGY	NN	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
OR	OR	NNP	I-NP	O
SENSITIVITY	SENSITIVITY	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
to	to	TO	B-PP	O
NSAID	NSAID	NNP	B-NP	O
'S	'S	NNP	I-NP	O
DEFINITE	DEFINITE	NNP	I-NP	O
ALLERGY	ALLERGY	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
OR	OR	NNP	I-NP	O
SENSITIVITY	SENSITIVITY	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
to	to	TO	B-PP	O
SALICYLATES	SALICYLATES	NNP	B-NP	O
DEFINITE	DEFINITE	NNP	I-NP	O
ALLERGY	ALLERGY	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
OR	OR	NNP	I-NP	O
SENSITIVITY	SENSITIVITY	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
to	to	TO	B-PP	O
G6PD	G6PD	NN	B-NP	O
DEFICIENCY	DEFICIENCY	NN	I-NP	O
Reason	Reason	NN	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
awware	awware	NN	B-NP	O
takes	take	VBZ	B-VP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
LASIX	LASIX	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
FUROSEMIDE	FUROSEMIDE	NN	I-NP	B-protein
-RRB-	-RRB-	HYPH	B-NP	I-protein
80	80	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
BID	BID	NN	I-NP	I-protein
HOLD	HOLD	NN	I-NP	I-protein
IF	IF	NN	I-NP	I-protein
:	:	:	O	O
sbp	sbp	NN	B-NP	O
<	<	JJR	B-NP	O
90	90	CD	I-NP	O
and	and	CC	O	O
call	call	VB	B-VP	O
ho	ho	JJ	B-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
5/5/03	5/5/03	CD	B-NP	O
by	by	IN	B-PP	O
COCCIA	COCCIA	NNP	B-NP	O
,	,	,	O	O
RENE	RENE	NNP	B-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
POSSIBLE	POSSIBLE	NNP	I-NP	O
ALLERGY	ALLERGY	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
OR	OR	NNP	I-NP	O
SENSITIVITY	SENSITIVITY	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
to	to	TO	B-PP	O
SULFA	SULFA	NNP	B-NP	O
POSSIBLE	POSSIBLE	NNP	I-NP	O
ALLERGY	ALLERGY	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
OR	OR	NNP	I-NP	O
SENSITIVITY	SENSITIVITY	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
to	to	TO	B-PP	O
SULFA	SULFA	NN	B-NP	O
Reason	Reason	NN	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-ADJP	O
has	have	VBZ	B-VP	O
tol	tol	NN	B-NP	O
Previous	Previous	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
Override	Override	NNP	I-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
5/5/03	5/5/03	CD	B-NP	O
by	by	IN	B-PP	O
TOTA	TOTA	NNP	B-NP	O
,	,	,	O	O
ENOCH	ENOCH	NNP	B-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
POSSIBLE	POSSIBLE	NNP	I-NP	O
ALLERGY	ALLERGY	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
OR	OR	NNP	I-NP	O
SENSITIVITY	SENSITIVITY	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
to	to	TO	B-PP	O
SULFA	SULFA	NNP	B-NP	O
POSSIBLE	POSSIBLE	NNP	I-NP	O
ALLERGY	ALLERGY	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
OR	OR	NNP	I-NP	O
SENSITIVITY	SENSITIVITY	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
to	to	TO	B-PP	O
SULFA	SULFA	NN	B-NP	O
Reason	Reason	NN	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
tolerates	tolerate	VBZ	B-VP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	B-DNA
ROBITUSSIN	ROBITUSSIN	NN	I-NP	I-DNA
-LRB-	-LRB-	NN	I-NP	I-DNA
GUAIFENESIN	GUAIFENESIN	NN	I-NP	I-DNA
-RRB-	-RRB-	NN	I-NP	I-DNA
10	10	CD	B-NP	I-DNA
MILLILITERS	MILLILITERS	NNS	I-NP	I-DNA
PO	PO	NN	I-NP	I-DNA
Q4H	Q4H	NN	I-NP	I-DNA
PRN	PRN	NN	I-NP	I-DNA
cough	cough	NN	I-NP	I-DNA
NIFEREX-150	NIFEREX-150	NN	I-NP	I-DNA
150	150	CD	I-NP	I-DNA
MG	MG	NN	I-NP	I-DNA
PO	PO	NN	I-NP	I-DNA
QD	QD	NN	I-NP	I-DNA
NITROGLYCERIN	NITROGLYCERIN	NN	I-NP	I-DNA
1/150	1/150	CD	I-NP	I-DNA
-LRB-	-LRB-	HYPH	I-NP	O
0.4	0.4	CD	I-NP	O
MG	MG	NN	I-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
1	1	CD	I-NP	O
TAB	TAB	NN	I-NP	O
SL	SL	NN	I-NP	O
q5min	q5min	NN	I-NP	O
x	x	SYM	B-NP	O
3	3	CD	I-NP	O
PRN	PRN	NN	I-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
HOLD	HOLD	NN	I-NP	O
IF	IF	NN	I-NP	O
:	:	:	O	O
SBP	SBP	NN	B-NP	B-protein
<	<	SYM	O	I-protein
100	100	CD	B-NP	I-protein
VITAMIN	VITAMIN	NN	I-NP	I-protein
B	B	NN	I-NP	I-protein
6	6	CD	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
PYRIDOXINE	PYRIDOXINE	NN	I-NP	I-protein
HCL	HCL	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
100	100	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
QD	QD	NNP	I-NP	I-protein
MVI	MVI	NNP	I-NP	I-protein
THERAPEUTIC	THERAPEUTIC	NNP	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
THERAPEUTIC	THERAPEUTIC	NNP	I-NP	I-protein
MULTIVITAMINS	MULTIVITAMINS	NN	I-NP	I-protein
-RRB-	-RRB-	HYPH	B-NP	I-protein
1	1	CD	I-NP	I-protein
TAB	TAB	NN	I-NP	I-protein
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
5/5/03	5/5/03	CD	B-NP	O
by	by	IN	B-PP	O
LAFANTANO	LAFANTANO	NN	B-NP	O
,	,	,	O	O
GRAHAM	GRAHAM	NNP	B-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
SIMVASTATIN	SIMVASTATIN	NNP	B-NP	O
&	&	CC	I-NP	O
NIACIN	NIACIN	NNP	I-NP	O
,	,	,	O	O
VIT	VIT	NNP	B-NP	O
.	.	.	O	O

B-3	B-3	NN	B-NP	B-protein
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
tol	tol	NN	B-NP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	B-DNA
ZOCOR	ZOCOR	NN	I-NP	I-DNA
-LRB-	-LRB-	NN	I-NP	I-DNA
SIMVASTATIN	SIMVASTATIN	NN	I-NP	I-DNA
-RRB-	-RRB-	NN	I-NP	I-DNA
20	20	CD	I-NP	I-DNA
MG	MG	NNP	I-NP	I-DNA
PO	PO	NNP	I-NP	I-DNA
QHS	QHS	NNP	I-NP	I-DNA
Food/Drug	Food/Drug	NNP	I-NP	I-DNA
Interaction	Interaction	NNP	I-NP	I-DNA
Instruction	Instruction	NNP	I-NP	I-DNA
Avoid	Avoid	NNP	I-NP	I-DNA
grapefruit	grapefruit	NN	I-NP	I-DNA
unless	unless	IN	B-SBAR	I-DNA
MD	MD	NN	B-NP	I-DNA
instructs	instruct	NNS	I-NP	I-DNA
otherwise	otherwise	RB	B-ADVP	O
.	.	.	O	O

Override	Override	NNP	B-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
5/5/03	5/5/03	CD	B-NP	O
by	by	IN	B-PP	O
DEMORANVILLE	DEMORANVILLE	NN	B-NP	O
,	,	,	O	O
NESTOR	NESTOR	NN	B-NP	B-protein
,	,	,	O	O
M.D.	M.D.	NN	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
MVI	MVI	NN	B-NP	O
THERAPEUTIC	THERAPEUTIC	NN	I-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
41789373	41789373	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
SIMVASTATIN	SIMVASTATIN	NNP	B-NP	O
&	&	CC	I-NP	O
NIACIN	NIACIN	NNP	I-NP	O
,	,	,	O	O
VIT	VIT	NNP	B-NP	O
.	.	.	O	O

B-3	B-3	NN	B-NP	B-protein
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
tol	tol	NN	B-NP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
TOPROL	TOPROL	NN	I-NP	O
XL	XL	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
METOPROLOL	METOPROLOL	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
SUST	SUST	NN	I-NP	O
.	.	.	O	O

REL	REL	NN	B-NP	B-protein
.	.	.	O	O
-RRB-	-RRB-	NNP	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O

100	100	CD	B-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
QD	QD	NN	I-NP	O
HOLD	HOLD	NN	I-NP	O
IF	IF	NN	I-NP	O
:	:	:	O	O
sbp	sbp	NN	B-NP	O
<	<	SYM	O	O
100	100	CD	B-NP	O
,	,	,	O	O
hr	hr	NN	B-NP	O
<	<	SYM	O	O
55	55	CD	B-NP	O
and	and	CC	O	O
call	call	VB	B-VP	O
ho	ho	NN	B-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Take	Take	NNP	I-NP	O
consistently	consistently	RB	B-ADVP	O
with	with	IN	B-PP	O
meals	meal	NNS	B-NP	O
or	or	CC	B-PP	O
on	on	IN	B-PP	O
empty	empty	JJ	B-NP	O
stomach	stomach	NN	I-NP	O
.	.	.	O	O

Number	Number	NN	B-NP	O
of	of	IN	B-PP	O
Doses	Dose	NNS	B-NP	O
Required	Require	VBN	B-VP	O
-LRB-	-LRB-	HYPH	B-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
5	5	CD	B-NP	O
IMDUR	IMDUR	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ISOSORBIDE	ISOSORBIDE	NN	I-NP	O
MONONIT	MONONIT	NN	I-NP	O
.	.	.	O	O

-LRB-	-LRB-	NN	B-NP	B-protein
SR	SR	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
-RRB-	-RRB-	HYPH	B-NP	O
30	30	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
BID	BID	NN	I-NP	O
HOLD	HOLD	NN	I-NP	O
IF	IF	NN	I-NP	O
:	:	:	O	O
sbp	sbp	NN	B-NP	O
<	<	SYM	O	O
100	100	CD	B-NP	O
and	and	CC	O	O
call	call	VB	B-VP	O
ho	ho	NN	B-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Give	Give	NNP	I-NP	O
on	on	IN	B-PP	O
an	an	DT	B-NP	O
empty	empty	JJ	I-NP	O
stomach	stomach	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
give	give	VBP	B-VP	O
1hr	1hr	NN	B-NP	O
before	before	IN	B-SBAR	O
or	or	CC	O	O
2hr	2hr	NN	B-NP	O
after	after	IN	B-SBAR	O
food	food	NN	B-NP	B-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
DIOVAN	DIOVAN	NNP	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
VALSARTAN	VALSARTAN	NNP	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
160	160	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
QD	QD	NNP	I-NP	I-protein
HOLD	HOLD	NN	I-NP	I-protein
IF	IF	NN	I-NP	I-protein
:	:	:	O	O
sbp	sbp	NN	B-NP	O
<	<	SYM	O	O
100	100	CD	B-NP	O
and	and	CC	O	O
call	call	VB	B-VP	O
ho	ho	JJ	B-NP	O
Number	Number	NNP	I-NP	O
of	of	IN	B-PP	O
Doses	Doses	NNP	B-NP	O
Required	Required	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
5	5	CD	B-NP	O
ALLEGRA	ALLEGRA	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
FEXOFENADINE	FEXOFENADINE	NN	I-NP	O
HCL	HCL	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
180	180	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Avoid	Avoid	NNP	I-NP	O
grapefruit	grapefruit	NN	I-NP	O
unless	unless	IN	B-SBAR	O
MD	MD	NN	B-NP	B-DNA
instructs	instruct	NNS	I-NP	I-DNA
otherwise	otherwise	RB	B-ADVP	O
.	.	.	O	O

POTASSIUM	POTASSIUM	NNP	B-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
SUSTAINED	SUSTAINED	NNP	I-NP	O
RELEASE	RELEASE	NNP	I-NP	O
10	10	CD	I-NP	O
MEQ	MEQ	NN	I-NP	O
PO	PO	NN	I-NP	O
QD	QD	NN	I-NP	O
Ingredients	Ingredient	NNS	I-NP	O
contain	contain	VBP	B-VP	O
10	10	CD	B-NP	O
MEQ	MEQ	NN	I-NP	O
KCL	KCL	NN	I-NP	O
QD	QD	NN	I-NP	O
COMBIVENT	COMBIVENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
IPRATROPIUM	IPRATROPIUM	NNP	I-NP	O
AND	AND	CC	O	O
ALBUTEROL	ALBUTEROL	NNP	B-NP	O
SULFATE	SULFATE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
2	2	CD	I-NP	O
PUFF	PUFF	NN	I-NP	O
INH	INH	NN	I-NP	O
QID	QID	NN	I-NP	O
ADVAIR	ADVAIR	NN	I-NP	O
DISKUS	DISKUS	VBZ	B-VP	O
500/50	500/50	CD	B-NP	O
-LRB-	-LRB-	HYPH	I-NP	O
FLUTICASONE	FLUTICASONE	NN	I-NP	O
PROPIONATE	PROPIONATE	NN	I-NP	O
/	/	SYM	B-NP	O
...	...	:	O	B-protein
-RRB-	-RRB-	SYM	B-NP	I-protein
1	1	CD	I-NP	I-protein
PUFF	PUFF	NN	I-NP	I-protein
INH	INH	NNP	I-NP	I-protein
BID	BID	NNP	I-NP	I-protein
LANTUS	LANTUS	NNP	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
INSULIN	INSULIN	NNP	I-NP	I-protein
GLARGINE	GLARGINE	NNP	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
60	60	CD	I-NP	I-protein
UNITS	UNITS	NNP	I-NP	I-protein
SC	SC	NNP	I-NP	I-protein
QD	QD	NNP	I-NP	I-protein
Starting	Starting	NNP	I-NP	I-protein
Today	Today	NNP	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
4/24	4/24	CD	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
Instructions	Instruction	NNPS	I-NP	O
:	:	:	O	O
please	please	VB	B-INTJ	O
check	check	VB	B-VP	O
your	your	PRP$	B-NP	O
fingerstick	fingerstick	NN	I-NP	O
glucose	glucose	NN	I-NP	O
prior	prior	JJ	B-ADJP	O
to	to	TO	B-PP	O
meals	meal	NNS	B-NP	O
and	and	CC	I-NP	O
bedtime	bedtime	NN	I-NP	O
.	.	.	O	O

METAMUCIL	METAMUCIL	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
PSYLLIUM	PSYLLIUM	NN	I-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
1	1	CD	I-NP	O
TSP	TSP	NN	I-NP	O
PO	PO	NN	I-NP	O
QD	QD	NN	I-NP	O
PROTONIX	PROTONIX	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
PANTOPRAZOLE	PANTOPRAZOLE	NN	I-NP	O
-RRB-	-RRB-	,	O	O
40	40	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
HUMALOG	HUMALOG	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
INSULIN	INSULIN	NNP	I-NP	O
LISPRO	LISPRO	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
SC	SC	NNP	I-NP	O
HUMALOG	HUMALOG	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
INSULIN	INSULIN	NNP	I-NP	O
LISPRO	LISPRO	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
6	6	CD	I-NP	O
UNITS	UNITS	NNP	I-NP	O
SC	SC	NNP	I-NP	O
QAM	QAM	NNP	I-NP	O
Instructions	Instruction	NNPS	I-NP	O
:	:	:	O	O
and	and	CC	O	O
use	use	VB	B-VP	O
humalog	humalog	NN	B-NP	O
as	as	IN	B-PP	O
your	your	PRP$	B-NP	O
sliding	slide	VBG	I-NP	O
scale	scale	NN	I-NP	O
as	as	IN	B-SBAR	O
you	you	PRP	B-NP	O
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
doing	do	VBG	I-VP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
ZAROXOLYN	ZAROXOLYN	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
METOLAZONE	METOLAZONE	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
2.5	2.5	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
4/5/03	4/5/03	CD	B-NP	O
by	by	IN	B-PP	O
:	:	:	O	O
POSSIBLE	POSSIBLE	NN	B-NP	O
ALLERGY	ALLERGY	NN	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
OR	OR	NNP	I-NP	O
SENSITIVITY	SENSITIVITY	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
to	to	TO	B-PP	O
SULFA	SULFA	NNP	B-NP	O
POSSIBLE	POSSIBLE	NNP	I-NP	O
ALLERGY	ALLERGY	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
OR	OR	NNP	I-NP	O
SENSITIVITY	SENSITIVITY	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
to	to	TO	B-PP	O
SULFA	SULFA	NN	B-NP	O
Reason	Reason	NN	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
takes	take	NNS	I-NP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	B-DNA
VIT	VIT	NN	I-NP	I-DNA
C	C	NN	I-NP	I-DNA
-LRB-	-LRB-	HYPH	B-NP	I-DNA
ASCORBIC	ASCORBIC	NN	I-NP	I-DNA
ACID	ACID	NN	I-NP	I-DNA
-RRB-	-RRB-	NN	I-NP	I-DNA
500	500	CD	I-NP	I-DNA
MG	MG	NNP	I-NP	I-DNA
PO	PO	NNP	I-NP	I-DNA
QD	QD	NNP	I-NP	I-DNA
VIT	VIT	NNP	I-NP	I-DNA
E	E	NNP	I-NP	I-DNA
-LRB-	-LRB-	NNP	I-NP	I-DNA
TOCOPHEROL-DL-ALPHA	TOCOPHEROL-DL-ALPHA	NNP	I-NP	I-DNA
-RRB-	-RRB-	NNP	I-NP	I-DNA
400	400	CD	I-NP	I-DNA
UNITS	UNITS	NNP	I-NP	I-DNA
PO	PO	NNP	I-NP	I-DNA
QD	QD	NNP	I-NP	I-DNA
AZITHROMYCIN	AZITHROMYCIN	NNP	I-NP	I-DNA
250	250	CD	I-NP	I-DNA
MG	MG	NN	I-NP	I-DNA
PO	PO	NN	I-NP	I-DNA
QD	QD	NN	I-NP	I-DNA
X	X	SYM	B-NP	I-DNA
4	4	CD	I-NP	I-DNA
Days	Day	NNPS	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Avoid	Avoid	NNP	I-NP	O
antacids	antacid	NNS	I-NP	O
Take	Take	VBP	B-VP	O
with	with	IN	B-PP	O
food	food	NN	B-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
8/20/03	8/20/03	CD	B-NP	O
by	by	IN	B-PP	O
:	:	:	O	O
POTENTIALLY	POTENTIALLY	NNP	B-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
SIMVASTATIN	SIMVASTATIN	NNP	B-NP	O
&	&	CC	I-NP	O
AZITHROMYCIN	AZITHROMYCIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
House	House	NN	B-NP	O
/	/	SYM	B-NP	O
2	2	CD	I-NP	O
gm	gm	NN	I-NP	O
Na	Na	NN	I-NP	O
/	/	SYM	B-VP	O
ADA	ADA	NN	B-NP	O
2000	2000	CD	I-NP	O
cals/day	cals/day	NN	I-NP	O
/	/	SYM	B-NP	O
Low	Low	NN	I-NP	O
saturated	saturate	VBD	B-VP	O
fat	fat	JJ	B-NP	O
low	low	JJ	I-NP	O
cholesterol	cholesterol	NN	I-NP	O
ACTIVITY	ACTIVITY	NN	I-NP	O
:	:	:	O	O
Walking	Walk	VBG	B-VP	O
as	as	IN	B-SBAR	O
tolerated	tolerate	VBN	B-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Dr.	Dr.	NNP	B-NP	O
Munford	Munford	NNP	I-NP	O
,	,	,	O	O
your	your	PRP$	B-NP	O
primary	primary	JJ	I-NP	O
care	care	NN	I-NP	O
doctor	doctor	NN	I-NP	O
,	,	,	O	O
AH	AH	NN	B-NP	O
4551805354	4551805354	CD	I-NP	O
,	,	,	O	O
call	call	NN	B-NP	O
for	for	IN	B-PP	O
an	an	DT	B-NP	O
appointment	appointment	NN	I-NP	O
for	for	IN	B-PP	O
within	within	IN	B-NP	O
2	2	CD	I-NP	O
weeks	week	NNS	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
,	,	,	O	O
Radiology	Radiology	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
mammogram	mammogram	NN	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
March	March	NNP	I-NP	O
,	,	,	O	O
9	9	CD	B-NP	O
:	:	SYM	O	O
15	15	CD	B-NP	O
am	am	NN	I-NP	O
scheduled	schedule	VBN	B-VP	O
,	,	,	O	O
ALLERGY	ALLERGY	NNP	B-NP	O
:	:	:	O	O
Percocet	Percocet	NNP	B-NP	O
,	,	,	O	O
Reglan	Reglan	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
metoclopramide	metoclopramide	NN	I-NP	O
hcl	hcl	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
Gantrisin	Gantrisin	NN	B-NP	B-protein
-LRB-	-LRB-	NN	I-NP	I-protein
sulfisoxazole	sulfisoxazole	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
,	,	,	O	O
Cephalosporins	Cephalosporin	NNS	B-NP	O
,	,	,	O	O
G6pd	G6pd	NN	B-NP	O
deficiency	deficiency	NN	I-NP	O
,	,	,	O	O
Lidocaine	Lidocaine	NN	B-NP	B-protein
-LRB-	-LRB-	NN	I-NP	I-protein
antihistamines	antihistamine	NNS	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
,	,	,	O	O
Iv	Iv	NN	B-NP	O
contrast	contrast	NN	I-NP	O
dyes	dye	NNS	I-NP	O
,	,	,	O	O
Aspirin	Aspirin	NN	B-NP	O
,	,	,	O	O
Codeine	Codeine	NN	B-NP	O
,	,	,	O	O
Neggram	Neggram	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
nalidixic	nalidixic	JJ	I-NP	O
acid	acid	NN	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
,	,	,	O	O
Lestrill	Lestrill	NNP	B-NP	O
,	,	,	O	O
Keflex	Keflex	NNP	B-NP	O
,	,	,	O	O
Sulfa	Sulfa	NNP	B-NP	O
,	,	,	O	O
Penicillins	Penicillins	NNP	B-NP	O
,	,	,	O	O
Flagyl	Flagyl	NNP	B-NP	O
,	,	,	O	O
Lidocaine	Lidocaine	NNP	B-NP	O
,	,	,	O	O
Codeine	Codeine	NNP	B-NP	O
ADMIT	ADMIT	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
:	:	:	O	O
chf	chf	NN	B-NP	O
PRINCIPAL	PRINCIPAL	NNP	I-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NN	B-NP	O
for	for	IN	B-PP	O
Causing	Cause	VBG	B-VP	O
Admission	Admission	NN	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
bronchitis	bronchitis	NN	I-NP	O
OTHER	OTHER	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
Asthma	Asthma	NNP	I-NP	O
HTN	HTN	NN	I-NP	B-protein
RAD	RAD	NN	I-NP	I-protein
G6PD	G6PD	NN	I-NP	I-protein
DEF	DEF	NN	I-NP	I-protein
?	?	.	O	O

H/O	H/O	NN	B-NP	O
CHF	CHF	NN	I-NP	O
IDDM	IDDM	NN	I-NP	O
h/o	h/o	NN	I-NP	O
ischemic	ischemic	JJ	I-NP	O
colitis	colitis	NN	I-NP	O
Arthritis	Arthritis	NN	I-NP	O
DJD	DJD	NN	I-NP	O
Allergic	Allergic	JJ	I-NP	O
rhinitis	rhinitis	NN	I-NP	O
Glaucoma	Glaucoma	NN	I-NP	O
Bursitis	Bursitis	NN	I-NP	O
S/P	S/P	NN	I-NP	O
appy	appy	JJ	B-ADJP	O
,	,	,	O	O
TAH	TAH	NN	B-NP	B-protein
,	,	,	O	O
Zenker	Zenker	NNP	B-NP	O
's	's	POS	B-NP	O
divertic	divertic	JJ	I-NP	O
removal	removal	NN	I-NP	O
hx	hx	NN	I-NP	O
dvt	dvt	NN	I-NP	O
1988	1988	CD	I-NP	O
obstructive	obstructive	JJ	I-NP	O
sleep	sleep	NN	I-NP	O
apnea	apnea	NN	I-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
none	none	NN	B-NP	O
OTHER	OTHER	NN	I-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
none	none	NN	I-NP	O
BRIEF	BRIEF	NN	I-NP	O
RESUME	RESUME	NN	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
75F	75F	NN	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-VP	O
CHF	CHF	NN	B-NP	O
2/2	2/2	CD	I-NP	O
diasystolic	diasystolic	JJ	I-NP	O
dysfxn	dysfxn	NN	I-NP	O
,	,	,	O	O
possible	possible	JJ	B-NP	O
asthma	asthma	NN	I-NP	O
,	,	,	O	O
HTN	HTN	NN	B-NP	B-protein
,	,	,	O	O
DM	DM	NN	B-NP	O
,	,	,	O	O
CAD	CAD	NN	B-NP	B-protein
,	,	,	O	O
p/w	p/w	NN	B-NP	O
wheeze/dyspnea	wheeze/dyspnea	NN	I-NP	O
&	&	CC	I-NP	O
SSCP	SSCP	NN	I-NP	O
&	&	CC	I-NP	O
diarrhea	diarrhea	NN	I-NP	O
,	,	,	O	O
likely	likely	RB	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
mild	mild	JJ	I-NP	O
vol	vol	NN	I-NP	O
.	.	.	O	O

overload	overload	NN	B-NP	O
&	&	CC	I-NP	O
bronchitis	bronchitis	NN	I-NP	O
,	,	,	O	O
hemodyn	hemodyn	NN	B-NP	O
.	.	.	O	O

stable	stable	JJ	B-NP	O
,	,	,	I-NP	O
7/28	7/28	CD	I-NP	O
&	&	CC	I-NP	O
8/25	8/25	CD	I-NP	O
on	on	IN	B-PP	O
room	room	NN	B-NP	O
air	air	NN	I-NP	O
,	,	,	O	O
ambulating	ambulate	VBG	B-VP	O
without	without	IN	B-PP	O
issue	issue	NN	B-NP	O
,	,	,	O	O
symptomatically	symptomatically	RB	B-VP	O
much	much	RB	I-VP	O
improved	improve	VBN	I-VP	O
,	,	,	O	O
to	to	TO	B-VP	O
followup	followup	VB	I-VP	O
as	as	IN	B-PP	O
outpt	outpt	NN	B-NP	O
for	for	IN	B-PP	O
further	further	JJ	B-NP	O
management	management	NN	I-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
CHF	CHF	NN	I-NP	B-protein
and	and	CC	I-NP	O
baseline	baseline	NN	I-NP	O
restrictive	restrictive	JJ	I-NP	O
lung	lung	NN	I-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

HPI	HPI	LS	B-LST	B-cell_type
:	:	:	O	O
-	-	HYPH	B-NP	O
see	see	NN	I-NP	O
problem	problem	NN	I-NP	O
list	list	NN	I-NP	O
for	for	IN	B-PP	O
past	past	JJ	B-NP	B-protein
med	me	VBN	I-NP	I-protein
hx	hx	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
extensive	extensive	JJ	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
-	-	HYPH	B-NP	O
pt	pt	NN	I-NP	O
last	last	RB	B-VP	O
seen	see	VBN	I-VP	O
ESMC	ESMC	NN	B-NP	B-DNA
2/10	2/10	CD	I-NP	I-DNA
-LRB-	-LRB-	HYPH	I-NP	O
3	3	CD	I-NP	O
days	day	NNS	I-NP	O
PTA	PTA	NN	I-NP	B-protein
-RRB-	-RRB-	SYM	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
substernal	substernal	JJ	I-NP	O
chest	chest	NN	I-NP	O
pressure	pressure	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
SSCP	SSCP	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
&	&	CC	I-NP	O
sob	sob	NN	I-NP	O
,	,	,	O	O
w	w	NN	B-NP	O
/	/	SYM	B-VP	O
diffuse	diffuse	JJ	B-NP	O
wheezes	wheeze	NNS	I-NP	O
,	,	,	O	O
RA	RA	NN	B-NP	B-protein
sat	sit	VBD	B-VP	I-protein
100	100	CD	B-NP	I-protein
%	%	NN	I-NP	I-protein
-	-	HYPH	O	I-protein
>	>	SYM	B-NP	I-protein
nebs	neb	NNS	I-NP	I-protein
,	,	,	O	O
Po	Po	NNP	B-NP	O
pred	pre	VBD	B-VP	O
,	,	,	O	O
d/c	d/c	NN	B-NP	O
from	from	IN	B-PP	O
obs	ob	NNS	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
in	in	IN	B-PP	O
24	24	CD	B-NP	O
hrs	hr	NNS	I-NP	O
w	w	JJ	B-NP	O
/	/	SYM	I-NP	O
short	short	JJ	I-NP	O
pred	pred	JJ	I-NP	O
taper	taper	NN	I-NP	O
.	.	.	O	O

Over	Over	IN	B-PP	O
next	next	JJ	B-NP	O
3	3	CD	I-NP	O
days	day	NNS	I-NP	O
,	,	,	O	O
breathing	breathing	NN	B-NP	O
got	get	VBD	B-VP	O
worse	worse	JJR	B-ADJP	O
,	,	,	O	O
developed	develop	VBD	B-VP	O
cough	cough	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
+	+	SYM	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
yellow	yellow	JJ	I-NP	O
sputum	sputum	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
FEVER	FEVER	NNP	I-NP	O
,	,	,	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
+	+	SYM	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
diarrhea	diarrhea	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
watery	watery	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
blood	blood	NN	I-NP	O
,	,	,	O	O
c/w	c/w	NN	B-NP	B-protein
chronic	chronic	JJ	I-NP	I-protein
colitis	colitis	NN	I-NP	I-protein
diarrhea	diarrhea	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
&	&	CC	I-NP	O
polyuria	polyuria	NN	I-NP	O
,	,	,	O	O
&	&	CC	B-NP	O
chest	ch	JJS	I-NP	O
pressure	pressure	NN	I-NP	O
worse	worse	JJR	I-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
cough	cough	NN	I-NP	O
better	good	JJR	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
SLNTG	SLNTG	NN	I-NP	B-protein
.	.	.	O	O

Pt	Pt	NN	B-NP	O
also	also	RB	B-ADVP	O
has	have	VBZ	B-VP	O
had	have	VBN	I-VP	O
increasing	increase	VBG	B-NP	O
LE	LE	NN	I-NP	O
edema	edema	NN	I-NP	O
,	,	,	O	O
recently	recently	RB	B-ADVP	O
had	have	VBD	B-VP	O
lasix	lasix	NN	B-NP	O
dose	dose	NN	I-NP	O
increased	increase	VBD	B-VP	O
by	by	IN	B-PP	O
CHF	CHF	NN	B-NP	B-protein
nurse	nurse	NN	I-NP	I-protein
.	.	.	O	O

On	On	IN	B-PP	O
DOA	DOA	NN	B-NP	B-protein
,	,	,	O	O
per	per	IN	B-PP	O
VNA	VNA	NN	B-NP	B-protein
-	-	HYPH	B-NP	I-protein
BS	BS	NN	I-NP	I-protein
in	in	IN	B-PP	O
200s	200s	CD	B-NP	O
,	,	,	O	O
BP	BP	NN	B-NP	B-protein
134/60	134/60	CD	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
baseline	baseline	NN	I-NP	I-protein
sbp	sbp	NN	I-NP	I-protein
100s	100s	CD	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
,	,	,	O	O
wt	wt	NN	B-NP	B-protein
5	5	CD	I-NP	I-protein
lb	lb	NN	I-NP	I-protein
decrease	decrease	NN	I-NP	I-protein
1	1	CD	B-NP	I-protein
night	night	NN	I-NP	I-protein
-LRB-	-LRB-	HYPH	B-NP	I-protein
218	218	CD	I-NP	I-protein
-	-	HYPH	B-NP	I-protein
>	>	SYM	I-NP	I-protein
213	213	CD	I-NP	I-protein
-RRB-	-RRB-	HYPH	I-NP	I-protein
so	so	RB	I-NP	O
sent	sent	JJ	I-NP	O
pt	pt	NN	I-NP	O
to	to	TO	B-PP	O
ED	ED	NN	B-NP	O
.	.	.	O	O

VS	VS	NN	B-NP	O
T	T	NN	I-NP	O
98.6	98.6	CD	I-NP	O
HR	HR	NN	I-NP	O
92	92	CD	B-NP	O
BP	BP	NN	I-NP	O
120/53	120/53	CD	B-NP	O
RA	RA	NN	I-NP	O
96	96	CD	B-NP	O
%	%	NN	I-NP	O
;	;	:	O	O
-LRB-	-LRB-	NN	B-NP	B-protein
+	+	CC	I-NP	O
-RRB-	-RRB-	NN	I-NP	B-protein
diffuse	diffuse	JJ	I-NP	I-protein
wheezes	wheeze	NNS	I-NP	I-protein
&	&	CC	I-NP	I-protein
rhonchi	rhonchi	AFX	I-NP	O
-	-	HYPH	O	O
>	>	SYM	B-NP	O
alb	alb	NN	I-NP	O
neb	neb	NN	I-NP	O
,	,	,	O	O
40	40	CD	B-NP	O
mg	mg	NN	I-NP	O
iv	iv	NN	I-NP	O
lasix	lasix	NN	I-NP	O
,	,	,	O	O
6u	6u	CD	B-NP	O
reg	reg	NN	I-NP	O
.	.	.	O	O

insulin	insulin	NN	B-NP	B-protein
4	4	CD	I-NP	I-protein
glc	glc	NN	I-NP	I-protein
336	336	CD	I-NP	I-protein
.	.	.	O	O

EKG	EKG	NNP	B-NP	O
&	&	CC	I-NP	O
Cxray	Cxray	NNP	I-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-VP	O
no	no	DT	B-NP	O
new	new	JJ	I-NP	O
significant	significant	JJ	I-NP	O
changes	change	NNS	I-NP	O
PROBLEM	PROBLEM	NN	I-NP	O
LIST	LIST	NN	I-NP	O
:	:	:	O	O
-LRB-	-LRB-	SYM	B-NP	O
1	1	CD	I-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
PULM	PULM	NN	I-NP	B-protein
-	-	HYPH	B-ADJP	O
per	per	IN	B-PP	O
pulm	pulm	NN	B-NP	O
eval	eval	NN	I-NP	O
as	as	IN	B-PP	O
outpt	outpt	NN	B-NP	O
,	,	,	O	O
including	include	VBG	B-PP	O
PFTs	PFT	NNS	B-NP	B-protein
,	,	,	O	O
no	no	DT	B-NP	O
asthma	asthma	NN	I-NP	O
,	,	,	O	O
likely	likely	RB	B-NP	O
CHF	CHF	NN	I-NP	B-protein
causing	cause	VBG	B-VP	O
wheezes	wheeze	NNS	B-NP	O
&	&	CC	I-NP	O
pt	pt	NN	I-NP	O
got	get	VBD	B-VP	O
no	no	DT	B-NP	O
benefit	benefit	NN	I-NP	O
from	from	IN	B-PP	O
steroids	steroid	NNS	B-NP	O
-LRB-	-LRB-	VBP	B-VP	O
a	a	DT	B-NP	O
-RRB-	-RRB-	NN	I-NP	B-protein
d/c	d/c	NN	I-NP	I-protein
steroids	steroid	NNS	I-NP	I-protein
4/8	4/8	CD	B-NP	I-protein
-LRB-	-LRB-	HYPH	I-NP	O
b	b	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
continued	continue	VBD	B-VP	O
outpt	outpt	JJ	B-NP	O
advair	advair	NN	I-NP	O
,	,	,	O	O
combivent	combivent	NN	B-NP	O
,	,	,	O	O
prn	prn	NN	B-NP	O
nebs	neb	NNS	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
c	c	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
chest	chest	NN	I-NP	O
pt	pt	NN	I-NP	O
bid	bid	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
d	d	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
cpap	cpap	NN	I-NP	O
qhs	qh	NNS	I-NP	O
as	as	IN	B-PP	O
per	per	IN	B-PP	O
home	home	NN	B-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
e	e	NN	I-NP	B-protein
-RRB-	-RRB-	HYPH	O	I-protein
4/8	4/8	CD	B-NP	I-protein
diuresis	diuresis	NN	I-NP	I-protein
-LRB-	-LRB-	HYPH	B-NP	I-protein
2.5	2.5	CD	I-NP	I-protein
L	L	NN	I-NP	I-protein
neg	neg	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
-LRB-	-LRB-	HYPH	B-NP	I-protein
f	f	NN	I-NP	I-protein
-RRB-	-RRB-	HYPH	O	O
7/28	7/28	CD	B-NP	O
o2	o2	NN	I-NP	O
sat	sit	VBD	B-VP	O
95	95	CD	B-NP	O
%	%	NN	I-NP	O
RA	RA	NN	I-NP	O
,	,	,	O	O
w	w	NN	B-NP	O
/	/	SYM	B-VP	O
her	her	PRP$	B-NP	O
usual	usual	JJ	I-NP	O
baseline	baseline	NN	I-NP	O
wheezes	wheeze	VBZ	B-VP	O
on	on	IN	B-PP	O
exam	exam	NN	B-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
g	g	NN	I-NP	B-protein
-RRB-	-RRB-	NN	I-NP	I-protein
may	may	MD	B-VP	O
need	need	VB	I-VP	O
high	high	JJ	B-NP	O
resolution	resolution	NN	I-NP	O
chest	chest	NN	I-NP	O
ct	ct	NN	I-NP	O
as	as	IN	B-PP	O
outpt	outpt	NN	B-NP	O
to	to	TO	B-VP	O
evaluate	evaluate	VB	I-VP	O
lung	lung	NN	B-NP	O
parenchyma	parenchyma	NN	I-NP	O
to	to	TO	B-VP	O
explain	explain	VB	I-VP	O
baseline	baseline	NN	B-NP	O
wheezes	wheeze	VBZ	B-VP	O
-LRB-	-LRB-	NN	B-NP	O
2	2	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
CV	CV	NN	I-NP	O
:	:	:	O	O
-LRB-	-LRB-	SYM	B-NP	O
i	i	NN	I-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
ischemia	ischemia	NN	I-NP	O
-	-	HYPH	O	O
-LRB-	-LRB-	SYM	O	O
a	a	DT	B-NP	O
-RRB-	-RRB-	NN	I-NP	B-protein
ruled	rule	VBD	B-VP	O
out	out	RP	B-PRT	O
for	for	IN	B-PP	O
MI	MI	NN	B-NP	O
by	by	IN	B-PP	O
cardiac	cardiac	JJ	B-NP	B-protein
enzymes	enzyme	NNS	I-NP	I-protein
,	,	,	O	O
no	no	DT	B-NP	O
ekg	ekg	NN	I-NP	O
changes	change	NNS	I-NP	O
.	.	.	O	O

-LRB-	-LRB-	NN	B-NP	B-protein
b	b	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
cont	cont	VBP	B-VP	O
cardiac	cardiac	JJ	B-NP	O
meds	med	NNS	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
asa	asa	NN	I-NP	O
,	,	,	O	O
statin	statin	NN	B-NP	O
,	,	,	O	O
bb	bb	NN	B-NP	O
,	,	,	O	O
nitrates	nitrate	VBZ	B-VP	O
-RRB-	-RRB-	NN	B-NP	B-protein
and	and	CC	O	O
no	no	DT	B-NP	O
further	further	JJ	I-NP	O
ischemic	ischemic	JJ	I-NP	O
issues	issue	NNS	I-NP	O
during	during	IN	B-PP	O
this	this	DT	B-NP	O
admit	admit	NN	I-NP	O
.	.	.	O	O

-LRB-	-LRB-	HYPH	O	B-protein
ii	ii	AFX	O	I-protein
-RRB-	-RRB-	HYPH	B-NP	O
pump	pump	NN	I-NP	O
-	-	HYPH	O	O
4/8	4/8	CD	B-NP	O
jvp	jvp	NN	I-NP	O
hard	hard	JJ	B-ADJP	O
to	to	TO	B-VP	O
assess	assess	VB	I-VP	O
2/2	2/2	CD	B-NP	O
neck	neck	NN	I-NP	O
obesity	obesity	NN	I-NP	O
but	but	CC	O	O
euvol	euvol	NN	B-NP	O
to	to	TO	B-PP	O
mildly	mildly	RB	B-NP	O
wet	wet	JJ	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
a	a	DT	B-NP	O
-RRB-	-RRB-	JJ	I-NP	B-protein
7/28	7/28	CD	I-NP	I-protein
goal	goal	NN	I-NP	I-protein
i	i	NN	I-NP	I-protein
<	<	SYM	B-NP	I-protein
0	0	CD	I-NP	I-protein
1-2	1-2	CD	I-NP	I-protein
L	L	NN	I-NP	I-protein
,	,	,	O	O
met	meet	VBD	B-VP	O
goal	goal	NN	B-NP	B-protein
-LRB-	-LRB-	HYPH	O	I-protein
2.5	2.5	CD	B-NP	I-protein
L	L	NN	I-NP	I-protein
-RRB-	-RRB-	SYM	B-NP	I-protein
-	-	HYPH	B-NP	O
>	>	SYM	I-NP	O
7/28	7/28	CD	I-NP	O
nearly	nearly	RB	I-NP	O
orthostatic	orthostatic	JJ	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
lying	lie	VBG	B-VP	O
sbp	sbp	NN	B-NP	O
100	100	CD	I-NP	O
,	,	,	O	O
hr	hr	NN	B-NP	B-protein
95	95	CD	I-NP	I-protein
-	-	HYPH	O	O
>	>	SYM	B-NP	O
standing	stand	VBG	B-VP	O
sbp	sbp	NN	B-NP	O
110	110	CD	I-NP	O
,	,	,	O	O
hr	hr	NN	B-NP	B-protein
112	112	CD	I-NP	I-protein
-RRB-	-RRB-	SYM	B-NP	I-protein
-	-	HYPH	I-NP	O
>	>	SYM	I-NP	O
change	change	NN	I-NP	O
to	to	TO	B-PP	O
home	home	NN	B-NP	O
PO	PO	NN	I-NP	O
lasix	lasix	CD	I-NP	O
-LRB-	-LRB-	HYPH	I-NP	O
80	80	CD	I-NP	O
po	po	SYM	I-NP	O
bid	bid	NN	I-NP	O
-RRB-	-RRB-	SYM	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	I-NP	O
prn	prn	NN	I-NP	O
iv	iv	NN	I-NP	O
as	as	IN	B-SBAR	O
needed	need	VBN	B-VP	O
for	for	IN	B-PP	O
I	I	PRP	B-NP	O
=O	=O	VBP	B-VP	O
or	or	CC	O	O
slightly	slightly	RB	B-NP	O
neg	neg	JJ	I-NP	O
500	500	CD	I-NP	O
cc	cc	NN	I-NP	O
.	.	.	O	O

-LRB-	-LRB-	NN	B-NP	O
b	b	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
cardiac	cardiac	JJ	I-NP	O
diet	diet	NN	I-NP	O
,	,	,	O	O
fluid	fluid	NN	B-NP	O
restriction	restriction	NN	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
being	be	VBG	B-VP	O
discharged	discharge	VBN	I-VP	O
near	near	IN	B-PP	O
euvolemia	euvolemia	NN	B-NP	O
on	on	IN	B-PP	O
po	po	NN	B-NP	O
lasix	lasix	NN	I-NP	O
for	for	IN	B-PP	O
f/u	f/u	NN	B-NP	O
of	of	IN	B-PP	O
weights	weight	NNS	B-NP	O
,	,	,	O	O
electrolytes	electrolyte	NNS	B-NP	O
,	,	,	O	O
and	and	CC	O	O
lasix	lasix	NN	B-NP	O
titration	titration	NN	I-NP	O
per	per	IN	B-PP	O
CHF	CHF	NN	B-NP	O
clinic/nurse	clinic/nurse	NN	I-NP	O
as	as	IN	B-PP	O
outpt	outpt	NN	B-NP	O
.	.	.	O	O

-LRB-	-LRB-	NN	B-NP	O
iii	iii	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
rhythm	rhythm	NN	I-NP	O
:	:	:	O	O
tele	tele	NN	B-NP	O
until	until	IN	B-PP	O
r/o	r/o	NN	B-NP	O
'd	'd	NN	I-NP	O
,	,	,	O	O
NSR	NSR	NN	B-NP	B-protein
without	without	IN	B-PP	O
further	further	JJ	B-NP	O
issues	issue	NNS	I-NP	O
3	3	CD	B-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
RENAL	RENAL	NN	I-NP	O
:	:	:	O	O
cr	cr	NN	B-NP	O
at	at	IN	B-PP	O
baseline	baseline	NN	B-NP	O
4/8	4/8	CD	I-NP	O
2.1	2.1	CD	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
a	a	DT	B-NP	O
-RRB-	-RRB-	NN	I-NP	B-protein
f/u	f/u	NN	I-NP	I-protein
cr	cr	NN	I-NP	I-protein
s/p	s/p	NN	I-NP	I-protein
diuresis	diuresis	NN	I-NP	I-protein
7/28	7/28	CD	I-NP	I-protein
stable	stable	JJ	I-NP	I-protein
2.0	2.0	CD	I-NP	I-protein
-LRB-	-LRB-	HYPH	I-NP	O
b	b	NN	I-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
replete	replete	JJ	I-NP	O
lytes	lyte	NNS	I-NP	O
prn	prn	VBP	B-VP	O
as	as	IN	B-SBAR	O
no	no	DT	B-NP	O
scales	scale	NNS	I-NP	O
,	,	,	O	O
final	final	JJ	B-NP	O
CR	CR	NN	I-NP	B-protein
2.2	2.2	CD	I-NP	I-protein
-LRB-	-LRB-	HYPH	I-NP	O
4	4	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
GI-protonix	GI-protonix	NN	I-NP	O
,	,	,	O	O
bowel	bowel	NN	B-NP	O
regimen	regimen	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
b	b	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
if	if	IN	B-SBAR	O
diarrhea	diarrhea	NN	B-NP	O
,	,	,	O	O
cx	cx	NN	B-NP	O
and	and	CC	O	O
send	send	NN	B-NP	O
stool	stool	NN	I-NP	O
leuks	leuk	VBZ	B-VP	O
however	however	RB	B-ADVP	O
on	on	IN	B-PP	O
7/28	7/28	CD	B-NP	O
formed	form	VBN	I-NP	O
BMs	BM	NNS	I-NP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
further	further	JJ	I-NP	O
issues	issue	NNS	I-NP	O
-LRB-	-LRB-	HYPH	O	O
5	5	CD	B-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
ENDO	ENDO	NN	I-NP	B-protein
-	-	HYPH	O	O
4/8	4/8	CD	B-NP	O
tsh	tsh	JJ	I-NP	O
0.097	0.097	CD	I-NP	O
-	-	HYPH	I-NP	O
levoxyl	levoxyl	NN	I-NP	O
DC	DC	NN	I-NP	O
'd	'd	NN	I-NP	O
,	,	,	O	O
recommend	recommend	VBP	B-VP	O
f/u	f/u	NN	B-NP	O
as	as	IN	B-SBAR	O
o/p	o/p	NN	B-NP	O
to	to	TO	B-VP	O
determine	determine	VB	I-VP	O
TSH	TSH	NN	B-NP	O
levels	level	NNS	I-NP	O
of	of	IN	B-PP	O
thyroid	thyroid	JJ	B-NP	O
replacement	replacement	NN	I-NP	O
.	.	.	O	O

b	b	NN	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Diabetes	Diabetes	NNP	I-NP	O
-	-	HYPH	B-NP	O
Her	Her	NNP	I-NP	O
Lantus	Lantus	NNP	I-NP	O
was	be	VBD	B-VP	O
increased	increase	VBN	I-VP	O
to	to	TO	B-PP	O
60	60	CD	B-NP	O
U	U	NN	I-NP	O
qd	qd	NN	I-NP	O
due	due	JJ	B-ADJP	O
to	to	TO	B-PP	O
persistent	persistent	JJ	B-NP	O
hyperglycemia	hyperglycemia	NN	I-NP	O
even	even	RB	B-ADVP	O
off	off	IN	B-PP	O
steroids	steroid	NNS	B-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
fingerstick	fingerstick	NN	I-NP	O
glucoses	glucose	NNS	I-NP	O
ranged	range	VBD	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
mid	mid	JJ	I-NP	O
200s	200s	CD	I-NP	O
to	to	TO	B-PP	O
lower	low	JJR	B-NP	O
300s	300s	CD	I-NP	O
prior	prior	JJ	B-ADVP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
increase	increase	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	O
glucose	glucose	NN	I-NP	O
control	control	NN	I-NP	O
should	should	MD	B-VP	O
continue	continue	VB	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
monitored	monitor	VBN	I-VP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
.	.	.	O	O

-LRB-	-LRB-	SYM	O	O
6	6	CD	B-NP	O
-RRB-	-RRB-	SYM	I-NP	O
HEME-cont	HEME-cont	JJ	I-NP	O
fe	fe	NN	I-NP	O
&	&	CC	I-NP	O
guaiac	guaiac	NN	I-NP	O
stools	stool	NNS	I-NP	O
7/28	7/28	CD	B-NP	O
hct	hct	NN	I-NP	O
stable	stable	JJ	B-ADJP	O
,	,	,	O	O
33.4	33.4	CD	B-NP	O
-LRB-	-LRB-	HYPH	I-NP	O
7	7	CD	I-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
FULL	FULL	NN	I-NP	O
code	code	NN	I-NP	O
for	for	IN	B-PP	O
this	this	DT	B-NP	O
admission	admission	NN	I-NP	B-protein
-LRB-	-LRB-	HYPH	B-NP	I-protein
8	8	CD	I-NP	I-protein
-RRB-	-RRB-	HYPH	I-NP	O
Health	Health	NNP	I-NP	O
maintenance	maintenance	NN	I-NP	O
-	-	HYPH	I-NP	O
mammogram	mammogram	NN	I-NP	O
rescheduled	reschedule	VBN	B-VP	O
for	for	IN	B-PP	O
March	March	NNP	B-NP	O
at	at	IN	B-PP	O
9	9	CD	B-NP	O
:	:	SYM	I-NP	O
15	15	CD	I-NP	O
am	am	NN	I-NP	O
.	.	.	O	O

-LRB-	-LRB-	SYM	O	O
9	9	CD	B-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
ID	ID	NN	I-NP	B-protein
-	-	HYPH	I-NP	O
Azithromycin	Azithromycin	NN	I-NP	O
Z-Pack	Z-Pack	NN	I-NP	O
started	start	VBD	B-VP	O
8/25	8/25	CD	B-NP	O
for	for	IN	B-PP	O
probable	probable	JJ	B-NP	O
sinusitis	sinusitis	NN	I-NP	O
.	.	.	O	O

Multiple	Multiple	JJ	B-NP	O
U/A	U/A	NN	I-NP	O
's	'	VBZ	I-NP	O
this	this	DT	B-NP	O
admission	admission	NN	I-NP	O
,	,	,	O	O
all	all	DT	B-NP	O
normal	normal	JJ	I-NP	O
or	or	CC	I-NP	O
contaminated/poor	contaminated/poor	JJ	I-NP	O
specimen	specimen	NN	I-NP	O
.	.	.	O	O

Final	Final	JJ	B-NP	O
repeat	repeat	NN	I-NP	O
pending	pende	VBG	B-PP	O
-LRB-	-LRB-	NN	B-NP	B-protein
sent	send	VBN	B-VP	O
for	for	IN	B-PP	O
LGF	LGF	NN	B-NP	B-protein
-RRB-	-RRB-	NN	I-NP	I-protein
.	.	.	O	O

ADDITIONAL	ADDITIONAL	JJ	B-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
Call	Call	VB	B-VP	O
your	your	PRP$	B-NP	O
doctor	doctor	NN	I-NP	O
or	or	CC	O	O
return	return	VB	B-VP	O
to	to	TO	B-VP	O
ED	ED	VBN	I-VP	O
if	if	IN	B-SBAR	O
any	any	DT	B-NP	O
of	of	IN	B-PP	O
your	your	PRP$	B-NP	O
symptoms	symptom	NNS	I-NP	O
,	,	,	O	O
such	such	JJ	B-PP	O
as	as	IN	I-PP	O
cough	cough	NN	B-NP	O
,	,	,	O	O
wheeze	wheeze	NN	B-NP	O
,	,	,	O	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
,	,	,	O	O
dizziness	dizziness	NN	B-NP	O
,	,	,	O	O
falling	fall	VBG	B-VP	O
,	,	,	O	O
diarrhea	diarrhea	NN	B-NP	O
,	,	,	O	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
return	return	NN	B-NP	O
,	,	,	O	O
worsen	worsen	VBN	B-VP	O
or	or	CC	O	O
change	change	NN	B-NP	O
in	in	IN	B-PP	O
any	any	DT	B-NP	O
way	way	NN	I-NP	O
concerning	concern	VBG	B-VP	O
to	to	TO	B-PP	O
you	you	PRP	B-NP	O
.	.	.	O	O

-LRB-	-LRB-	SYM	O	O
2	2	CD	B-NP	O
-RRB-	-RRB-	HYPH	O	O
Take	Take	VB	B-VP	O
your	your	PRP$	B-NP	O
medications	medication	NNS	I-NP	O
and	and	CC	O	O
see	see	VB	B-VP	O
your	your	PRP$	B-NP	O
doctor	doctor	NN	I-NP	O
as	as	IN	B-SBAR	O
instructed	instruct	VBN	B-VP	O
above	above	IN	B-PP	O
;	;	:	O	O
note	note	NN	B-NP	O
that	that	IN	B-SBAR	O
levoxyl	levoxyl	NN	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
discontinued	discontinue	VBN	I-VP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
-LRB-	-LRB-	NN	B-NP	O
1	1	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Follow	Follow	NNP	I-NP	O
for	for	IN	B-PP	O
resolution	resolution	NN	B-NP	O
of	of	IN	B-PP	O
sinusitis	sinusitis	NN	B-NP	O
,	,	,	O	O
bronchitis	bronchitis	NN	B-NP	O
.	.	.	O	O

-LRB-	-LRB-	SYM	O	O
2	2	CD	B-NP	O
-RRB-	-RRB-	SYM	I-NP	O
F/u	F/u	NN	I-NP	O
volume	volume	NN	I-NP	O
status	status	NN	I-NP	O
,	,	,	O	O
daily	daily	JJ	B-NP	O
wts	wt	NNS	I-NP	O
on	on	IN	B-PP	O
current	current	JJ	B-NP	O
lasix	lasix	NN	I-NP	O
dose	dose	NN	I-NP	O
,	,	,	O	O
adjust	adjust	VBP	B-VP	O
as	as	IN	B-SBAR	O
needed	need	VBN	B-VP	O
.	.	.	O	O

-LRB-	-LRB-	SYM	O	O
3	3	CD	B-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
F/u	F/u	NN	I-NP	O
electrolytes	electrolyte	NNS	I-NP	O
with	with	IN	B-PP	O
lasix	lasix	NN	B-NP	O
diuresis	diuresis	NN	I-NP	O
as	as	IN	B-PP	O
outpt	outpt	NN	B-NP	O
.	.	.	O	O

-LRB-	-LRB-	SYM	O	O
4	4	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
consider	consider	VBP	B-VP	O
high	high	JJ	B-NP	O
resolution	resolution	NN	I-NP	O
CT	CT	NN	I-NP	O
scan	scan	NN	I-NP	O
of	of	IN	B-PP	O
chest	chest	NN	B-NP	O
to	to	TO	B-PP	O
eval	eval	NN	B-NP	O
.	.	.	O	O

lung	lung	NN	B-NP	O
parenchyma	parenchyma	NN	I-NP	O
re	re	NN	I-NP	O
:	:	:	O	O
chronic	chronic	JJ	B-NP	O
wheezes	wheeze	NNS	I-NP	O
.	.	.	O	O

-LRB-	-LRB-	SYM	O	O
5	5	CD	B-NP	O
-RRB-	-RRB-	SYM	I-NP	O
Repeat	Repeat	NN	I-NP	O
TSH	TSH	NN	I-NP	O
,	,	,	O	O
as	as	IN	B-SBAR	O
levoxy	levoxy	NN	B-NP	O
was	be	VBD	B-VP	O
d/c	d/c	NN	B-NP	O
while	while	IN	B-SBAR	O
here	here	RB	B-ADVP	O
.	.	.	O	O

-LRB-	-LRB-	SYM	O	O
6	6	CD	B-NP	O
-RRB-	-RRB-	SYM	O	O
TO	TO	TO	B-VP	O
VNA	VNA	NN	I-VP	B-protein
-	-	HYPH	B-NP	O
Assess	Assess	NN	I-NP	O
o2	o2	NN	I-NP	O
sats	sat	NNS	I-NP	O
,	,	,	O	O
volume	volume	NN	B-NP	O
status	status	NN	I-NP	O
,	,	,	O	O
orthostatics	orthostatic	NNS	B-NP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
sugars	sugar	NNS	I-NP	O
,	,	,	O	O
home	home	NN	B-NP	O
safety	safety	NN	I-NP	O
,	,	,	O	O
PO	PO	NN	B-NP	O
intake	intake	NN	I-NP	O
,	,	,	O	O
bowel	bowel	NN	B-NP	O
movements	movement	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
medication	medication	NN	B-NP	O
compliance	compliance	NN	I-NP	O
.	.	.	O	O

-LRB-	-LRB-	SYM	O	O
7	7	CD	B-NP	O
-RRB-	-RRB-	SYM	I-NP	O
pt	pt	NN	I-NP	O
may	may	MD	B-VP	O
benefit	benefit	VB	I-VP	O
from	from	IN	B-PP	O
home	home	NN	B-NP	O
physical	physical	JJ	I-NP	O
therapy	therapy	NN	I-NP	O
No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
LOZITO	LOZITO	NNP	B-NP	O
,	,	,	O	O
NATHANIAL	NATHANIAL	NNP	B-NP	O
NESTOR	NESTOR	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
-	-	HYPH	B-NP	O
HEME	HEME	NNP	I-NP	B-protein
ONC	ONC	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
VI35	VI35	CD	I-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
8/20/03	8/20/03	CD	I-NP	O
@	@	SYM	I-NP	O
01	01	CD	I-NP	O
******	******	SYM	I-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

